CME Group Inc. (NASDAQ:CME) Shares Sold by Rockefeller Capital Management L.P.

Rockefeller Capital Management L.P. trimmed its position in CME Group Inc. (NASDAQ:CME - Free Report) by 3.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 106,264 shares of the financial services provider's stock after selling 3,264 shares during the period. Rockefeller Capital Management L.P.'s holdings in CME Group were worth $24,675,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of CME. SJS Investment Consulting Inc. lifted its stake in CME Group by 570.6% in the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider's stock worth $26,000 after purchasing an additional 97 shares in the last quarter. New Age Alpha Advisors LLC increased its holdings in shares of CME Group by 50.0% in the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock valued at $30,000 after purchasing an additional 43 shares during the last quarter. Financial Life Planners purchased a new position in CME Group during the fourth quarter worth approximately $32,000. Knuff & Co LLC acquired a new position in CME Group during the fourth quarter worth $33,000. Finally, Fortitude Family Office LLC grew its holdings in CME Group by 120.3% in the 4th quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider's stock valued at $35,000 after buying an additional 83 shares in the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Stock Up 0.4 %

Shares of CME stock traded up $1.14 during trading hours on Friday, reaching $262.53. 1,794,607 shares of the stock were exchanged, compared to its average volume of 2,142,838. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $273.42. The business's fifty day moving average is $256.78 and its two-hundred day moving average is $240.16. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The firm has a market capitalization of $94.60 billion, a P/E ratio of 27.15, a P/E/G ratio of 6.76 and a beta of 0.43.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. As a group, research analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Friday, March 7th were paid a dividend of $1.25 per share. This is a boost from CME Group's previous quarterly dividend of $1.15. The ex-dividend date was Friday, March 7th. This represents a $5.00 annualized dividend and a yield of 1.90%. CME Group's payout ratio is presently 51.71%.

Analysts Set New Price Targets

Several brokerages have recently weighed in on CME. Royal Bank of Canada reissued a "sector perform" rating and set a $269.00 price target on shares of CME Group in a research report on Thursday, April 3rd. Piper Sandler raised their price target on shares of CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a report on Tuesday, April 8th. Erste Group Bank upgraded CME Group to a "strong-buy" rating in a research report on Monday, March 17th. Barclays upped their price target on CME Group from $263.00 to $279.00 and gave the company an "equal weight" rating in a research note on Monday, April 7th. Finally, Keefe, Bruyette & Woods upped their target price on shares of CME Group from $256.00 to $257.00 and gave the company a "market perform" rating in a research report on Friday, February 14th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $247.47.

Insider Activity at CME Group

In other CME Group news, insider Julie Winkler sold 11,592 shares of the company's stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $249.17, for a total value of $2,888,378.64. Following the completion of the transaction, the insider now owns 21,885 shares in the company, valued at $5,453,085.45. This represents a 34.63 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Howard J. Siegel sold 10,000 shares of CME Group stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $260.00, for a total value of $2,600,000.00. Following the sale, the director now owns 21,873 shares in the company, valued at $5,686,980. This trade represents a 31.37 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 27,076 shares of company stock valued at $6,871,496 over the last three months. 0.30% of the stock is owned by corporate insiders.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.